Sanofi India announced that Charles Billard, Chief Financial Officer and Whole Time Director of the Company will relocate outside of India to take up a new role within Sanofi group. He will therefore step down as the Chief Financial Officer and Whole Time Director of the Company with effect from the end of the day on 30 September 2020. He will cease to be the Key Managerial Personnel of the Company with effect from the end of the day on 30 September 2020.

The Board of Directors of the Company on 16th September 2020 approved resignation of Charles Billard as the Chief Financial Officer and Whole Time Director. Charles Billard will however continue to be engaged with the Company as a Non-Executive Director.

Powered by Capital Market - Live News

The Board of Sanofi India has approved the appointment of Rahul Bhatnagar (DIN 07268064) and Marc-Antoine Lucchini (DIN 08812302) as Additional Directors (Non-Executive) of the company with effect from 29 July 2020.

Powered by Capital Market - Live News

Net profit of Sanofi India rose 39.94% to Rs 136.30 crore in the quarter ended June 2020 as against Rs 97.40 crore during the previous quarter ended June 2019. Sales declined 5.00% to Rs 710.50 crore in the quarter ended June 2020 as against Rs 747.90 crore during the previous quarter ended June 2019.

Powered by Capital Market - Live News

Sanofi India will hold a meeting of the Board of Directors of the Company on 28 July 2020.

Powered by Capital Market - Live News